Medicare Enrolled

Dr. Paula Fishbaugh, MD

Obstetrics & Gynecology · Royal Oak, MI
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
326 N MAIN ST, Royal Oak, MI 48067
2485847600
In practice since 2005 (20 years)
NPI: 1073504866 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Fishbaugh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fishbaugh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Fishbaugh

Dr. Paula Fishbaugh is an obstetrics & gynecology specialist in Royal Oak, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Fishbaugh performed 31 Medicare services across 31 unique beneficiaries.

Between the years covered by Open Payments, Dr. Fishbaugh received a total of $2,777 from 41 pharmaceutical and/or device companies across 115 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in obstetrics & gynecology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Fishbaugh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 31 Medicare services $2,777 industry payments

Medicare Practice Summary

Medicare Utilization ↗
31
Medicare services
Bottom 27% in MI for obstetrics & gynecology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
31
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Pelvic and clinical breast exam for cancer screening
A physical examination of the pelvis and breasts to screen for cervical or vaginal cancer. This procedure involves a clinical assessment performed by a healthcare provider.
 19 $40 $75
Pap smear screening test
A screening test to collect and prepare a cervical or vaginal sample for laboratory analysis.
 12 $43 $75
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,777
Total received (2018-2024)
Avg $397/year across 7 years
Top 17% in MI for obstetrics & gynecology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
115
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,726 (98.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$51 (1.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$397
2023
$514
2022
$943
2021
$202
2020
$205
2019
$316
2018
$200

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Axonics, Inc.
$116
Aspira Women's Health Inc
$86
Sage Therapeutics, Inc.
$61
Organon Llc
$40
PFIZER INC.
$23
ABBVIE INC.
$20
Daiichi Sankyo Inc.
$18
Hologic Sales and Service, LLC
$17
CooperSurgical, Inc.
$16
Top 3 companies account for 66.5% of 2024 payments
All-time payments by company (2018-2024) ›
Meditrina
$292
Hologic, LLC
$252
Aspira Women's Health Inc
$212
Medtronic, Inc.
$211
Sage Therapeutics, Inc.
$134
Axonics, Inc.
$116
ABBVIE INC.
$102
AbbVie Inc.
$102
CooperSurgical, Inc.
$88
Daiichi Sankyo Inc.
$81
Lupin Inc.
$80
Minerva Surgical, Inc
$76
Sumitomo Pharma America, Inc.
$67
Exeltis, USA Inc.
$66
PFIZER INC.
$61
AbbVie, Inc.
$59
Covidien LP
$53
Organon LLC
$52
Merck Sharp & Dohme Corporation
$51
AMAG Pharmaceuticals, Inc.
$51
Myovant Sciences Inc.
$49
Evofem Biosciences, Inc.
$47
Mylan Pharmaceuticals Inc.
$44
Organon Llc
$40
Hologic Sales and Service, LLC
$37
MAYNE PHARMA COMMERCIAL LLC
$34
Allergan Inc.
$34
Allergan, Inc.
$33
Ferring Pharmaceuticals Inc.
$30
TherapeuticsMD, Inc.
$27
Gynesonics, Inc.
$26
Ethicon US, LLC
$24
Bayer Healthcare Pharmaceuticals Inc.
$23
Bayer HealthCare Pharmaceuticals Inc.
$20
Agile Therapeutics, Inc.
$19
Smith+Nephew, Inc.
$14
Mission Pharmacal Company
$14
Avion Pharmaceuticals
$14
Duchesnay USA Incorporated
$14
DySIS Medical, Inc.
$13
Medicem Inc.
$12
Top 3 companies account for 27.2% of all-time payments
Associated products mentioned in payments ›
ABRYSVO · ACESSA PROVU SYSTEM · ANNOVERA · Aveta · Axonics · BOTOX · Balcoltra · CERVIDIL · CitraNatal · CoolSeal Generator · DILAPAN-S · Endometrial Ablation System (Device) · GARDASIL 9 · IMVEXXY · INJECTAFER · INTRAROSA · JADA SYSTEM · LILETTA · LO LOESTRIN FE · MYFEMBREE · Mara Console · Minerva ES · Mirena · Myosure · NEXPLANON · NOVASURE · NovaSure · Novasure · ORILISSA · OVA1 · Omniscope · Orilissa · Osphena · PREMARIN · Paragard · Phexxi · Prineo 42 · SLYND · SOLOSEC · SOLOSEC-CEEK · SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM · SUPRAX · Stravix · TruClear · Twirla · Ultra 2.0 · V-LOC 180 · Xulane · ZULRESSO · ZURZUVAE · myosure
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an obstetrics & gynecology specialist in Royal Oak?
Compare obstetricians & gynecologists in the Royal Oak area by procedure volume, costs, and industry payment transparency.
Browse obstetricians & gynecologists nearby

Geographic Context

Obstetricians & gynecologists within 10 mi
756
Per 100K population
59.4
County median income
$95,296
Nearest hospital
HENRY FORD HEALTH BEHAVIORAL HEALTH HOSPITAL
2.2 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Fishbaugh is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 17% of MI peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Fishbaugh experienced with pelvic and clinical breast exam for cancer screening?
Based on Medicare claims data, Dr. Fishbaugh performed 19 pelvic and clinical breast exam for cancer screening services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fishbaugh receive payments from pharmaceutical companies?
Yes. Dr. Fishbaugh received a total of $2,777 from 41 companies across 115 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fishbaugh's costs compare to other obstetricians & gynecologists in Royal Oak?
Dr. Fishbaugh's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fishbaugh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Obstetricians & Gynecologists in Royal Oak
Browse obstetricians & gynecologists in Royal Oak ranked by procedure volume and transparency data.
Highest volume
Top Obstetricians & Gynecologists in MI
Obstetricians & gynecologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Obstetricians & Gynecologists in MI
Which MI obstetricians & gynecologists receive the most from drug and device companies.
By company
Meditrina Payments to Doctors
See all physicians who received payments from Meditrina.
By company
Hologic, LLC Payments to Doctors
See all physicians who received payments from Hologic, LLC.
By company
Aspira Women's Health Inc Payments to Doctors
See all physicians who received payments from Aspira Women's Health Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →